Yahoo! Finance: Top Stories

Wall Street Shows Love for Kymera Stock After Biotech’s Promising Drug Trial

Jun 7, 2025 - 03:20
 0
Wall Street Shows Love for Kymera Stock After Biotech’s Promising Drug Trial
Read More

Tags:

Previous Article

Morgan Stanley Maintains Hold Rating on Snowflake (SNOW), Keeps $200 PT

Next Article

X Reforms API Pricing as It Seeks More Revenue Options

Related Posts

GlobalWafers Plans Additional $4 Billion Investment in U.S.

GlobalWafers Plans Additional $4 Billion Investment in ...

May 17, 2025  0

Special Situation Alert: Salesforce Acquisition Pushes Informatica (INFA) Onto STAMPEDE List

Special Situation Alert: Salesforce Acquisition Pushes ...

May 28, 2025  0

Stocks, dollar gain on US-China trade talks, detail needed

Stocks, dollar gain on US-China trade talks, detail needed

May 12, 2025  0